Cover Image

Cumulative life course impairment: Evidence for hidradenitis suppurativa

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Maneli Doroudian Tehrani, Ruby S. Gibson, Corey L. Snyder, Martina L. Porter, Alexa B. Kimball
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Journal of the European Academy of Dermatology and Venereology
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Genomic and proteomic insights into hidradenitis suppurativa
by: Maria Argyropoulou, et al.
Published: (2026)

Botulinum toxin type A efficacy on pain and suppuration in hidradenitis suppurativa
by: Noor F. Goandal, et al.
Published: (2025)

International consensus statement on the use of ultrasound in hidradenitis suppurativa
by: X. Wortsman, et al.
Published: (2025)

Gender Equity and Academic Dermatology: Are we giving the right advice?
by: Alexa B. Kimball
Published: (2024)

Ultrasound features of hidradenitis suppurativa tunnels treated with bimekizumab
by: Alberto Soto‐Moreno, et al.
Published: (2026)

Mental health in hidradenitis suppurativa: A complex matter
by: Klasiena Bouwman, et al.
Published: (2024)

Methodological concerns in hidradenitis suppurativa genomic and proteomic profiling
by: Emmanouil Stylianakis, et al.
Published: (2026)

Methodological considerations on genomic and proteomic profiling in hidradenitis suppurativa
by: Yixuan He, et al.
Published: (2026)

New‐onset anxiety in paediatric patients with hidradenitis suppurativa
by: E. Cohn, et al.
Published: (2024)

Towards the development of upgrade criteria for the treatment of hidradenitis suppurativa with biologics
by: Georgios Nikolakis, et al.
Published: (2025)

Out‐of‐pocket expenses of hidradenitis suppurativa: A cross‐sectional study
by: M. Delage‐Toriel, et al.
Published: (2025)

Assessment of metabolic dysfunction‐associated steatotic liver disease in patients with hidradenitis suppurativa: A cross‐sectional study
by: N. Omari, et al.
Published: (2024)

Combined thermography and ultrasound in hidradenitis suppurativa: A preliminary study
by: Flavia Manzo Margiotta, et al.
Published: (2026)

How can we improve patient care in hidradenitis suppurativa?
by: Maria Polina Konstantinou, et al.
Published: (2026)

Real‐world adalimumab survival and discontinuation factors in hidradenitis suppurativa
by: Patricia Garbayo‐Salmons, et al.
Published: (2024)

First steps into AI‐supported hidradenitis suppurativa severity assessment
by: Thrasyvoulos Tzellos
Published: (2024)

Impact of semaglutide use in obese and diabetic patients with hidradenitis suppurativa
by: Marielos I. Posada Posada, et al.
Published: (2024)

Diagnostic delay for hidradenitis suppurativa: No change in the 2015–2024 decade
by: Tonia Samela, et al.
Published: (2026)

Impact of smoking on disease severity and treatment outcomes in hidradenitis suppurativa
by: Amanda Holmen Poulsen, et al.
Published: (2026)

European S2k guidelines for hidradenitis suppurativa/acne inversa part 2: Treatment
by: C. C. Zouboulis, et al.
Published: (2024)

Presence of draining tunnels denotes a distinct hidradenitis suppurativa phenotype
by: Thrasyvoulos Tzellos, et al.
Published: (2025)

Large language models in evaluating hidradenitis suppurativa from clinical images
by: Mehdi Boostani, et al.
Published: (2025)

Delphi consensus: First‐line use of biologics and small molecules in hidradenitis suppurativa
by: Georgios Nikolakis, et al.
Published: (2026)

Re‐exploring management of hidradenitis suppurativa: A call for imaging and procedural inclusion
by: Anju George
Published: (2025)

Head and neck manifestations associated with hidradenitis suppurativa: A retrospective multicentre study
by: Olivier Cogrel, et al.
Published: (2026)

Prevalence of risk factors affecting the use of oral JAK inhibitors in hidradenitis suppurativa
by: Ditte Georgina Zhang, et al.
Published: (2025)

Gender differences in pain interference with daily activities and functional impairment among patients with hidradenitis suppurativa: A population‐based study in the United States
by: Paige Kingston, et al.
Published: (2025)

Short‐term efficacy of biologics in moderate‐to‐severe hidradenitis suppurativa: A systematic review and NMA
by: Haley B. Naik, et al.
Published: (2025)

Long‐term efficacy of biologics in moderate‐to‐severe hidradenitis suppurativa: A systematic review and MAIC
by: Thrasyvoulos Tzellos, et al.
Published: (2026)

Hair follicle stem cell fate supports distinct clinical endotypes in hidradenitis suppurativa
by: Audrey Onfroy, et al.
Published: (2025)

Real‐world outcomes of biologics for hidradenitis suppurativa: A systematic review and meta‐analysis
by: Jia Qi Adam Bai, et al.
Published: (2026)

The WHO ‐5 well‐being measure as an assessment tool in eczema, hidradenitis suppurativa and psoriasis
by: Emily Pender, et al.
Published: (2025)

Familial Mediterranean fever and MEFV gene variants in hidradenitis suppurativa: A systematic review
by: Katherine Aw, et al.
Published: (2024)

Phenolization as a treatment option for sinus tracts in hidradenitis suppurativa: A pilot study
by: Céline Eldani, et al.
Published: (2024)

Reply to “Improved clinical effectiveness of adalimumab when initiated with clindamycin and rifampicin in hidradenitis suppurativa”
by: Fabrizio Martora, et al.
Published: (2024)

Low satisfaction with medical care among patients with hidradenitis suppurativa: A multicenter study
by: Kerstin Wolk, et al.
Published: (2025)

Comparative effect of metformin and SGLT2i on vascular risk and mortality in hidradenitis suppurativa
by: Alfonso Gotor‐Rivera, et al.
Published: (2025)

From ‘nice to have’ to ‘must have’: Integrating ultrasound into routine care of hidradenitis suppurativa
by: Eva Vilarrasa
Published: (2026)

Bimekizumab efficacy using IHS4 outcomes in hidradenitis suppurativa: Results from BE HEARD I and II
by: Thrasyvoulos Tzellos, et al.
Published: (2026)

Efficacy and safety of biologics for hidradenitis suppurativa: A network meta‐analysis of phase III trials
by: Laura Calabrese, et al.
Published: (2025)